(Brunzell et al., 2003). In contrast, withdrawal from cedures)
. On test day, animals are drug free and allowed to roam between the two sides. If a drug has chronic nicotine in rats decreases CREB, phosphorylated CREB, and CRE-DNA binding in the cortex and been experienced as reinforcing, animals will spend considerably more time on the side of the chamber that amygdala (Pandey et al., 2001). Thus, the role of CREB in mediating the long-term plasticity that may underlie was paired with the drug. To examine the effects of repeated nicotine administration on pCREB levels, we the development of nicotine addiction is poorly understood.
utilized the same number and frequency of nicotine injections used in the behavioral assessment of nicotine Human imaging, clinical, and laboratory studies indicate that nicotine craving and smoking relapse can be reward. Of interest, pCREB levels were increased only in the VTA and striatum 20 min following repeated nicotriggered by environmental cues associated with smoking behavior (Brody et al., 2002; Childress et al., 1999). tine ( Figure 3 ). However, 24 hr following repeated nicotine administration there were no increases in pCREB As smokers self-administer nicotine within the context of specific environmental stimuli, cues may not only inlevels in any brain regions examined (Figure 3) . Although acute and repeated nicotine administration fluence the degree to which nicotine is self administered, but they may become as important to smoking clearly increases CREB phosphorylation in some brain regions, it is not known whether exposure to an envibehavior as nicotine itself (Caggiula et al., 2002). Therefore, the goals of the present studies were to determine ronment previously paired with nicotine is able to induce a similar effect. Therefore, we trained mice in a what molecular mechanisms are activated during nicotine administration, if these mechanisms are similarly conditioned place preference paradigm with 1.0 mg/kg or 2.0 mg/kg nicotine. Lower doses of nicotine (0.1, engaged during reexposure to environmental cues associated with nicotine delivery, and whether these mech-0.25, and 0.5 mg/kg) did not produce any significant preference or aversion (data not shown), and levels of anisms are necessary and sufficient to sustain the behavioral responses associated with nicotine reward. pCREB were not evaluated following these doses. Levels of pCREB were examined immediately following exposure to the place preference chambers, 24 hr folResults lowing the last nicotine administration. While levels of pCREB were not increased in animals that received To investigate the mechanisms underlying nicotine nicotine in their home cage at this time, pCREB levels reinforcement, we examined the activation of CREB were significantly increased in the VTA, cingulate corvia phosphorylation (pCREB). Twenty minutes followtex, NAc, and PPT in animals that had prior exposure ing acute nicotine treatment, pCREB-positive cells are to nicotine in the conditioning boxes ( Figure 3 ). The inmarkedly increased in the VTA (Figure 1 ). To evaluate crease in the NAc and PPT may be due in part to the the effect of opioid receptor blockade on this response, significant increase in pCREB levels in response to sawe examined the levels of pCREB following acute nicoline conditioning alone, while increases in VTA and cintine in animals that had been pretreated with naloxone.
gulate cortex appear to be specific to exposure to the Nicotine-induced increases in pCREB are blocked in nicotine-conditioned environment (Figure 3 ). the VTA with naloxone pretreatment (Figure 1) .
As acute nicotine administration induced increases Naloxone has some affinity for all subtypes of opioid in pCREB that were blocked by pretreatment with nalreceptors. Therefore, to establish the specificity of this oxone, the effects of naloxone on environment-induced antagonist, we utilized MOR −/− mice and examined increase in pCREB were examined as well. A single inpCREB induction in the VTA after an acute injection of jection of naloxone administered 24 hr after the last nicotine. In the wild-type animals, nicotine treatment nicotine injection blocked the conditioned increase in resulted in an increase in pCREB-positive cells in the pCREB in both the VTA and NAc ( Figures 4A and 4B ). VTA (Figure 2 ) as seen previously; however, nicotineThe behavioral significance of blocking CREB phosinduced increases in pCREB were absent in the MOR −/− phorylation after exposure to an environment previmice (Figure 2 ). These data confirm that the ability of ously paired with nicotine was determined in condinaloxone to attenuate nicotine-induced increases in tioned place preference experiments. Animals in which pCREB occurs through the MOR. pCREB was elevated showed significant preference to To examine the extent to which nicotine increases the nicotine-paired side of the conditioning chamber CREB phosphorylation throughout the brain, we mea-( Figure 4C ). In contrast, at a higher dose (2.0 mg/kg), sured pCREB levels in a number of brain regions assoanimals found nicotine aversive as indicated by the fact ciated with reward, dopamine signaling, and learning that animals spend significantly less time on the side and conditioning. In addition to the VTA, pCREB levels of the chamber that was paired with nicotine. Of interwere increased in the NAc, striatum, and pedunculoest, a dose of 2.0 mg/kg of nicotine did not produce a pontine tegmental nucleus (PPT) following a single adchange in pCREB levels in the VTA (data not shown). ministration of nicotine (Figure 3) . In contrast, pCREB Pretreatment with naloxone on test day only blocked levels were not affected in the substantia nigra, hippothe reinforcing effects of nicotine at 1.0 mg/kg but not campus, or cingulate cortex by acute nicotine adminthe aversive effects seen at 2.0 mg/kg. These data reistration (Figure 3) . veal that activation of CREB is associated with the conThe rewarding or aversive effects of drugs can be ditioned behavioral reward expressed following nicoevaluated through the use of conditioned place prefertine place preference. Moreover, a single injection of ence. During the course of the experiment, mice are naloxone on the test day was sufficient to attenuate confined to one side of a testing chamber or the other and receive nicotine (for details, see Experimental Prothis increase in environment-conditioned CREB phos- phorylation and to block the rewarding effects of nicpreference, naloxone was administered on test day of a cocaine-conditioned place preference paradigm. Beotine.
To examine the specificity of the effects of MOR havioral responses and changes in pCREB levels in the VTA and NAc were examined. In the VTA, there was blockade, including changes in pCREB and subsequent alterations in the expression of conditioned place no effect of cocaine-conditioned place preference on pCREB levels, nor was there an effect of naloxone pretreatment ( Figure 5A ). In contrast, there was an increase in pCREB levels in the NAc on test day, but unlike nicotine conditioning, this increase was not affected by pretreatment with naloxone ( Figure 5B ). Naloxone administration on test day did not block the expression of cocaine-conditioned place preference ( Figure 5C ). These data suggest that the effects of naloxone on pCREB levels as well as conditioned behavior are specific to nicotine and not generalized to cocaine. Pharmacologic tools, such as naloxone, allow us to manipulate the activity of CREB indirectly through modulation of the opioid receptor. To directly examine CREB activity, and the functional significance of these increases in pCREB, we utilized CREB aD mutant mice in conditioned place preference for nicotine. We pre- nicotine at 1.0 mg/kg were absent in the CREB aD mu- tant mice ( Figure 6 ). In contrast, the aversive properties sulted in an increase in MOR mRNA in the VTA in wildtype mice but not in CREB aD mutant mice ( Figure 7A ). of nicotine, evident at 2.0 mg/kg, were not altered by CREB deficiency and were comparable to the response This upregulation of MOR mRNA appears to be specific for nicotine, as MOR mRNA levels were not significantly seen in wild-type controls.
The present data demonstrate that a genetic defidifferent in wild-type or CREB aD mutant mice following cocaine administration. Furthermore, within the mesociency (CREB mutation) and a pharmacological manipulation (MOR antagonism) have remarkably similar eflimbic dopamine reward pathway, this increase in MOR mRNA was specific to the VTA, as levels were not alfects on rewarding properties of nicotine. However, one caveat of genetic models such as CREB aD mutant mice tered in the NAc ( Figure 7B ). While cocaine administration induced changes in MOR mRNA in the NAc, this is that functional compensation can occur due to the absence of the gene product throughout development.
effect is equivalent in wild-type and CREB aD mutant mice. Thus, putative CREB target genes, such as the MOR, which contains a CRE sequence in its promoter (Min et To determine if the nicotine-dependent changes in MOR mRNA levels are due to a direct activation of the al., 1994), could be particularly susceptible to altered regulation in these mice. However, there was no differ-MOR gene by CREB, we performed in vivo chromatin immunoprecipitation (ChIP) assays. ChIPs were perence in MOR mRNA levels in the VTA and NAc between wild-type and CREB aD mutant mice ( Figure 7A ), sugformed using chromatin obtained from the VTA of saline-and nicotine-treated mice. To quantify the degree gesting that constitutive loss of CREB had not altered any systems responsible for the basal regulation of the of MOR promoter enrichment, we performed real-time PCR of the immunoprecipitated material with primers MOR gene in these areas. In contrast, repeated nicotine administration in the conditioned place preference parsurrounding the CRE. Chromatin precipitation with the CREB-specific antibody resulted in 1.8-fold enrichment adigm (1.0 mg/kg, once every other day for 8 days) re- et al., 1994) . However, the associated with cigarette smoking. Given the results represence of the CRE sequence in the promoter or enported here, clinical studies designed to evaluate adhancer of a gene alone is not sufficient to characterize ministration of opioid antagonists just prior to cues asit as a direct target of CREB, nor does it predict that sociated with smoking could lead to a more promising CREB mediates its regulation. There are no differences treatment regimen. in basal levels of MOR mRNA expression between wildtype and CREB α⌬ mutant mice that could account for 
